Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Duchenne muscular dystrophy gene and cancer.

Cellular oncology (Dordrecht, Netherlands) - 1 Feb 2021

Jones Leanne, Naidoo Michael, Machado Lee R, Anthony Karen

Abstract excerpt

BACKGROUND: Mutation of the Duchenne muscular dystrophy (DMD) gene causes Duchenne and Becker muscular dystrophy, degenerative neuromuscular disorders that primarily affect voluntary muscles. However, increasing evidence implicates DMD in the development of all major cancer types. DMD is a large gene with 79 exons that codes for the essential muscle protein dystrophin. Alternative promotor usage drives the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dystrophin
Share to DMD gene
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Models, Biological

Share to Muscular Dystrophy, Duchenne

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33188621
DOI: 10.1007/s13402-020-00572-y
PMCID: PMC7906933

Genes

DMD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Duchenne muscular dystrophy gene and cancer.PMID 33188621Read ↗

Downregulation of dystrophin expression occurs across diverse tumors, correlates with the age of onset, staging and reduced survival of patientsSemantic proximity Read ↗

Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations.Semantic proximity Read ↗

DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.Semantic proximity Read ↗

Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma.Semantic proximity Read ↗

Dystrophin is a tumor suppressor in human cancers with myogenic programs.Semantic proximity Read ↗

Duchenne muscular dystrophy: gene and gene product; mechanism of mutation in the gene.Semantic proximity Read ↗

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies.Semantic proximity Read ↗

Duchenne muscular dystrophy caused by a novel deep intronic DMD mutation.Semantic proximity Read ↗

Characterization of a Dmd (EGFP) reporter mouse as a tool to investigate dystrophin expression.Semantic proximity Read ↗

Dystrophin and mutations: one gene, several proteins, multiple phenotypes.Semantic proximity Read ↗

Clinical and molecular consequences of exon 78 deletion in DMD gene.Semantic proximity Read ↗

Regulation of DMD pathology by an ankyrin-encoded miRNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.